MyFinsight
Home
Blog
About
Contact
Download
Download image
DE
$79,407K
(21.67%↑ Y/Y)
FR
$76,189K
(36.71%↑ Y/Y)
Other International
Markets
$56,898K
(33.97%↑ Y/Y)
JP
$37,786K
(16.02%↑ Y/Y)
Net income (loss)
-$136,227K
(19.21%↑ Y/Y)
Income tax
-$23K
(-100.06%↓ Y/Y)
US
$385,632K
(-1.57%↓ Y/Y)
International Markets
$250,280K
(27.67%↑ Y/Y)
CN
$19,441K
(11.82%↑ Y/Y)
Total income (loss)
before income taxes
-$136,250K
(-3.88%↓ Y/Y)
Financial (expenses)
income, net
$17,550K
(-55.38%↓ Y/Y)
Net revenues
$655,353K
(8.28%↑ Y/Y)
Operating income (loss)
-$153,800K
(9.79%↑ Y/Y)
Gross profit
$488,474K
(4.37%↑ Y/Y)
Cost of revenues
$166,879K
(21.65%↑ Y/Y)
Total operating costs
and expenses
$642,274K
(0.59%↑ Y/Y)
Sales and marketing
$240,064K
(0.42%↑ Y/Y)
Research, development and
clinical studies
$224,544K
(7.11%↑ Y/Y)
General and
administrative
$177,666K
(-6.41%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
NovoCure Ltd (NVCR)
NovoCure Ltd (NVCR)